DETECTION OF BCR-ABL TRANSCRIPTS BY PCR IN PATIENTS 10 YEARS OR MORE AFTER BMT FOR CML

被引：0
|
作者：
LIN, F [1 ]
VANRHEE, F [1 ]
CROSS, NCP [1 ]
GOLDMAN, JM [1 ]
机构：
[1] HAMMERSMITH HOSP,RPMS,LRF,LEUKAEMIA UNIT,LONDON W12 0HS,ENGLAND
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A215 / A215
页数：1
相关论文
共 50 条
  • [31] Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay
    Preudhomme, C
    Révillion, F
    Merlat, A
    Hornez, L
    Roumier, C
    Duflos-Grardel, N
    Jouet, JP
    Cosson, A
    Peyrat, JP
    Fenaux, P
    LEUKEMIA, 1999, 13 (06) : 957 - 964
  • [32] Mixed hematopoietic chimerism in myeloid cells is associated with relapse in BCR-ABL positive patients after unmanipulated BMT for CML
    Román, J
    Serrano, J
    Jiménez, A
    Castillejo, JA
    Navarro, JA
    Rubio, IG
    Pascual, A
    Sánchez, J
    Maldonado, J
    Torres, A
    BONE MARROW TRANSPLANTATION, 1999, 23 : S50 - S50
  • [33] Increase of BCR-ABL/ABL Ratio That Corresponds to BCR-ABL Mutation Detection In Chronic Myeloid Leukemia (CML) Patients Treated by Imatinib (IM)
    Tsaur, Grigory
    Popov, Alexander
    Ivanova, Anna
    Yakovleva, Yulia
    Riger, Tatyana
    Plekhanova, Olga
    Ivanets, Yulia
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    FASEB JOURNAL, 2011, 25
  • [34] Abnormally small BCR-ABL transcripts in CML patients before and during imatinib treatment.
    Khorashad, Jamshid S.
    Lipton, Jeffrey H.
    Marin, David
    Milojkovic, Dragana
    Cross, Nicholas C. P.
    Dibb, Nicholas
    Melo, Junia V.
    Kamel-Reid, Suzanne
    Goldman, John M.
    Apperley, Jane F.
    Kaeda, Jaspal S.
    BLOOD, 2006, 108 (11) : 611A - 611A
  • [35] BCR-ABL mutation testing in patients with CML occurrence prior to a 10X rise in BCR-ABL test results.
    Smyth, Carol
    Bhan, Jason M.
    Sorokina, Tatiana
    Dhaliwal, Ajitpal Singh
    Parikh, Niyati
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Monitoring of Dynamics of BCR-ABL Transcripts Over Time Using Digital PCR Assay In CP CML Patients After Achieving Complete Molecular Remission
    Goh, Hyun-Gyung
    Kim, Dongho
    Choi, Soo-Young
    Kim, Soo-Hyun
    Lee, Jeong
    Lee, Young-Seok
    Oh, Sang-Mi
    Kim, Dong-Wook
    BLOOD, 2010, 116 (21) : 722 - 722
  • [37] Detection and quantitation of BCR-ABL transcripts using a comprehensive quantitative RT-PCR analysis system for minimal residual disease in CML patients.
    Guo, JQ
    Lin, H
    Lin, F
    Champlin, R
    Talpaz, M
    Kantarjian, HM
    Andreeff, M
    Zhao, S
    Glassman, A
    Arlinghaus, R
    BLOOD, 2000, 96 (11) : 255B - 255B
  • [38] Significance of quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α based therapy.
    Martinelli, G
    Testoni, N
    Amabile, M
    Bonifazi, F
    Farabegoli, P
    Terragna, C
    Montefusco, V
    Ottaviani, E
    Saglio, G
    Russo, D
    Baccarani, M
    Rosti, G
    Tura, S
    BLOOD, 1998, 92 (10) : 368B - 368B
  • [39] Quantitative detection of bcr-abl transcripts in chronic myeloid leukemia
    Menif, S.
    Zarrouki, S.
    Jeddi, R.
    ben Alaya, N.
    Ali, Z. BelHadj
    Ben Abid, H.
    Hdeiji, S.
    Elloumi, M.
    Khlif, A.
    Meddeb, B.
    Dellagi, K.
    PATHOLOGIE BIOLOGIE, 2009, 57 (05): : 388 - 391
  • [40] BCR-ABL transcript levels and BCR-ABL/BCR transcript ratios in CML patients with good or bad response to treatment.
    Moravcová, J
    Regner, J
    Brezinová, J
    Klamová, H
    BLOOD, 2001, 98 (11) : 264B - 264B
12345